A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis

Clinical trial NCT06066125 · COMPLETED

Trial details

NCT number: NCT06066125
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriasis Skin Diseases

Start date: 2023-03-31
Primary completion: 2024-08-19
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.